BrightSpec
Waltham, US · Founded 2012 · Delaware corporation · 26 employees on LinkedIn · 3 known investors
BrightSpec develops molecular rotational resonance (MRR) spectroscopy instruments and software that identify and quantify gas-phase molecules from complex mixtures without front-end separation. Its analytical platforms serve the pharmaceutical, chemical, and consumer goods industries for tasks such as structure validation, residual analysis, and raw material characterization.
Founders & leadership

Board


Investors · 3
Reported raises · per SEC filings
Form D private placements$17.1M disclosed across 5 rounds · 2017–2025
▶$3.9MraisedMay 2025 · 7 investors · Other TechnologyRule 506(b)
- Jenny RookeDirector
- Timothy GermannDirector
- David CashDirector
- Walter ColsmanExecutive Officer, Director
- Dan KidleDirector
- Offering amount
- $11.1M
- Amount sold
- $3.9M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedDec 2022 · 24 investors · Other TechnologyRule 506(b)
- Walter ColsmanExecutive Officer, Director
- David CashDirector
- Terry DunlayDirector
- Jenny RookeDirector
- Dan KidleDirector
- Offering amount
- $15M
- Amount sold
- $7.5M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$825KraisedOct 2021 · 7 investors · Other TechnologyRule 506(b)
- Terry DunlayDirector
- George KastendikeDirector
- Robert CreedenDirector
- David CashDirector
- Walter ColsmanExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $825K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedMar 2019 · 5 investors · Other TechnologyRule 506(b)
- ROBERT LLOYDExecutive Officer, Director
- DAVID CASHDirector
- JAFFRAY WOODRIFFDirector
- WALTER COLSMANDirector
- ROBERT CREEDENDirector
- Offering amount
- $2.7M
- Amount sold
- $2.1M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.8MraisedAug 2017 · 3 investors · Other TechnologyRule 506(b)
- JAFFRAY WOODRIFFDirector
- ROBERT LLOYDExecutive Officer, Director
- THOMAS JONESDirector
- DAVID MCDANIELExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.8M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapCompanies competing with BrightSpec for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.6M |
| U.S. ArmyArmy | Phase II | 2017 | $998.8K |
| National Science Foundation | Phase II | 2016 | $746.1K |
| U.S. ArmyArmy | Phase II | 2015 | $999.2K |
| National Science Foundation | Phase I | 2015 | $149.9K |
| U.S. ArmyArmy | Phase I | 2013 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does BrightSpec do?
- BrightSpec develops molecular rotational resonance (MRR) spectroscopy instruments and software that identify and quantify gas-phase molecules from complex mixtures without front-end separation. Its analytical platforms serve the pharmaceutical, chemical, and consumer goods industries for tasks such as structure validation, residual analysis, and raw material characterization.
- Who are BrightSpec's investors?
- BrightSpec's investors include Arboretum Ventures, Genoa Ventures, Medvest Capital.
- How much funding has BrightSpec raised?
- BrightSpec has disclosed $17.1M raised across 5 rounds.
- Where is BrightSpec headquartered?
- BrightSpec is headquartered in Waltham, US.






